Close
AI in Healthcare & Pharma Summit Boston 2026

MDCPartners Introduces Medical Expert Search Tool for Biopharma with New “Podium” App

AI Summary

MDCPartners introduces Podium, an online application for Clinical Ops, Medical Affairs teams and Medical Science Liaisons. The technology is based on the organization’s well-known clinical business intelligence solution ta-Scan, which effortlessly delivers in-depth and clear profiles of all relevant Key Opinion Leaders and Key External Experts.

The application also categorizes these expert profiles by their medical relevance and professional credentials. The ranking is based on the experts’ past and current clinical research activity and their experience levels within various disease areas.

The growing need for a user-friendly and up-to-date database of expert profiles led to the development of Podium. This mobile enterprise tool compresses hours of internet searching to a few clicks.

“Increasing scrutiny how pharma engages with therapeutic leaders has created a new demand in selection and evidence-based approaches to rank KOLs by fair market value,” commented David Cocker, Chief Scientific Officer at MDCPartners. Podium is powered by ta-Scan’s semantic search system: a user types in some medical filters, and Podium returns a list of potential KOL names, their rank, and therapeutic relevance. Tapping the résumé icon reveals a full profile. The patented Trial Cloud® and web mining software of ta-Scan, which is the largest semantically linked clinical database available on the web, combined with its powerful search capabilities, allows users to quickly find and analyze clinical expert data from multiple global public sources.

This new mobile application is a milestone in the product portfolio of MDCPartners. As a company which provides clinical intelligence and consultancy, MDCPartners believes it is crucial to gain greater insights into the therapeutic area expert landscape.

The pharmaceutical industry rarely announces its most significant shifts loudly. The signals are there — if you know where to look.

The Pharma Advancement briefing is how the sector’s most informed professionals stay ahead of those signals — covering drug development, regulatory affairs, manufacturing, and market access across every major region.

  • The stories pharmaceutical professionals will be discussing tomorrow, in your inbox today
  • Analysis that goes beyond the headline — written for readers who already understand the industry
  • The briefing that the sector’s most informed professionals open first

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES